You searched for viral vector - Page 21 of 53

Lysogene gene therapy Sanfillipo A obs study

News and Trends 29 Mar 2017

French Gene Therapy Biotech Gets Ready for Phase II/III

…leads to permanent tissue damage and paralysis. Lysogene wants to replace the faulty gene causing the disease with a gene therapy approach. The company uses an adenoviral vector (rAAVrH10), which…

March 29, 2017 - 3 minutesmins - By Melanie De Almeida

In Depth 15 Dec 2022

To avoid stagnation, the EU must refine its ATMP regulation

…traditional pills as they can be based on living cells or viral vectors that carry a DNA payload. They have the potential to stop a disease in its tracks with…

December 15, 2022 - 8 minutesmins - By Jonathan Smith

gene therapy bacteria ilya pharma lactic acid

News and Trends 23 Mar 2022

Ilya Pharma Paves Way for Bacterial Gene Therapy with €8.5M Funding

…in probiotics for a long time,” said Vågesjö. “As the bacteria are the product, I think [the manufacturing process] is easier than for recombinant proteins, adenoviral vectors, or any type…

March 23, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 30 Nov 2016

This was Labiotech Refresh! Check our recap and highlight video!

…across the UK! GeneQuine uses a unique viral vector for gene therapy targeting osteoarthritis that has already shown efficacy in horses. Moirai Biodesign is developing a test device to diagnose…

November 30, 2016 - 5 minutesmins - By Clara Rodríguez Fernández

Impacting vaccine development: COVID-19 and its implications for the future of vaccines

…vaccine technology platforms. Where traditionally vaccines have relied on inactivated whole viruses, virus subunits or viral vectors, the COVID-19 vaccine race advanced more innovative platforms such as gene vaccines. “Gene…

November 3, 2022 - 8 minutesmins - By Sudha Sundaram

spinal muscular atrophy zolgensma novartis gene therapy

News and Trends 30 Oct 2019

Trial Testing Spinal Application of Zolgensma Put on Hold by FDA

…gene into patients’ cells by means of a viral vector. The intravenous version of Zolgensma was approved by the FDA in May this year for patients under two years of…

October 30, 2019 - 2 minutesmins - By Jonathan Smith

Best in Biotech 11 Jul 2024

From data to discovery: Five bioinformatics companies you should know in 2024

…assembly for their research and development (R&D) projects. Synthace has previously worked with tech giants like Microsoft to design manufacturing processes for lentiviral vectors to be able to program cells…

July 11, 2024 - 7 minutesmins - By Roohi Mariam Peter

Podcast 19 Jan 2024

Epigenetic editing – the power of CRISPR without cutting DNA

…work in human cells. This enables in vivo or ex vivo delivery via a single viral vector. Epic’s lead program, EPI-321, is in IND-enabling studies for the treatment of facioscapulohumeral…

January 19, 2024 - 6 minutesmins - By Jim Cornall

BioNTech Production scaled e1584385495951

News and Trends 29 Apr 2020

Update: BioNTech and Pfizer’s mRNA Vaccine for Covid-19 Tested in Humans

…of a Covid-19 viral vector vaccine developed by the University of Oxford. BioNTech and Pfizer also plan to start clinical trials for the same vaccine in the US as soon…

April 29, 2020 - 5 minutesmins - By Helen Albert

News and Trends 17 Nov 2016

UniQure takes an axe to its Pipeline and Workforce in new R&D Strategy

…competitor in hemophilia, Spark Therapeutics, recently reported an unwanted immune response against its gene therapy’s viral vector. Shire, another rival, dropped its hemophilia B gene therapy earlier this year; this…

November 17, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 2 Jul 2020

Freeline Closes €106M Series C to Progress Hemophilia Gene Therapy

…and hemophilia A. The company will also expand its gene therapy manufacturing capacity. The company’s technology consists of delivering therapeutic DNA into patients via a viral vector. The technology has…

July 2, 2020 - 3 minutesmins - By Helen Albert

News and Trends 12 Sep 2016

Grüßgott, get to Meet 9 exciting Biotechs from Vienna

…viral vectors that can induce both protective antibodies and strong cytotoxic CD8+ T-cell responses. Its first product is HB101, a vaccine to prevent infection with human cytomegalovirus (hCMV), which has…

September 12, 2016 - 6 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: viral vector

French Gene Therapy Biotech Gets Ready for Phase II/III

To avoid stagnation, the EU must refine its ATMP regulation

Ilya Pharma Paves Way for Bacterial Gene Therapy with €8.5M Funding

This was Labiotech Refresh! Check our recap and highlight video!

Impacting vaccine development: COVID-19 and its implications for the future of vaccines

Trial Testing Spinal Application of Zolgensma Put on Hold by FDA

From data to discovery: Five bioinformatics companies you should know in 2024

Epigenetic editing – the power of CRISPR without cutting DNA

Update: BioNTech and Pfizer’s mRNA Vaccine for Covid-19 Tested in Humans

UniQure takes an axe to its Pipeline and Workforce in new R&D Strategy

Freeline Closes €106M Series C to Progress Hemophilia Gene Therapy

Grüßgott, get to Meet 9 exciting Biotechs from Vienna

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!